Friday, 22 Jun 2018

You are here

The RheumNow Week in Review - 16 February 2018

Dr. Jack Cush reviews highlights, news and recent research published this week on RheumNow.com. This week's report includes news on social media, new rituximab indications, steroid complications, DECT in Gout, T2T in gout, Dementia and rheumatology numbers.

  1. Cambridge study shows that hand thermoregulation is more dependant on muscle mass and not fat - this may be why more women than men bothered by "cold hands" https://t.co/j5zCt3ntW8
  2. Pharmacovigilance using Twitter? A UK study compared glucocorticoid AE on Twitter vs UK MHRA regulatory system; in 3 yrs, Twitter Identified 20,210 Steroid AE, but only 3022 via MHRA. Twitter AE “common but not serious”, most being insomnia and weight gain https://buff.ly/2o8LW9F
  3. FDA grants priority review for Genentechs Rituxan for use in pemphigus vulgaris https://t.co/e6uKQOf55f
  4. 240,000 Canadian COPD patients, >55 yrs; those on inhaled corticosteroids (>4 yrs, >1gm) had 10% higher rate of fractures (men and women) https://t.co/N4rJwrfohY
  5. Systematic review of DECT Scanning in Gout included 32 articles & 1502 pts. DECT takes little time and has low radiation exposure but limited availability. It showed Sensitivity & Specificity > 80%. Dx performance was better than Xray, CT, equal to US https://t.co/GkbSKNP7D2   
  6. Although epratuzumab (anti-CD22 MAb) failed in SLE in two phase III clinical trials, subanalyses show that pts w/ secondary Sjogrens who were SSA positive (7.1% of 1584 enrolled) where more likely to have a BICLA response and decreases in B cells and IgM. https://t.co/n6Woy8rTka
  7. T2T Improves Primary Care Gout Management  
  8. DMARDs Lower Dementia Risk in Rheumatoid Arthritis  40% reduction; 50% w/ MTX 
  9. NHANES Survey Shows OA Rising and RA Declining 

 

Disclosures: 
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

The RheumNow Week in Review – EULAR18 Epilogue (6.22.18)

Dr. Jack Cush reviews EULAR 2018 and the past week's news and reports from RheumNow.com, including DMARDs in OA, the price of Penicillamine, Infections when ANCA+, CV outcomes in gout, NSAIDs in Pregnancy and Seropostive vs. Seronegative Outcomes.

CDC Obesity Prevalence Higher in the Rural USA

MMWR reports that approximately 46 million persons (14%) in the United States live in nonmetropolitan counties, where there is a higher prevalence of obesity-associated chronic diseases such as diabetes, coronary heart disease, and arthritis. (Citation source: http://bit.ly/2lj5yql)

EULAR 2018 - Podcast from Day 4

This EULAR 2018 Podcast is a compilation of audio clips from EULAR in Amsterdam.

Click HERE to listen.

You can also listen on iTunes, Soundcloud or Stitcher.

EULAR 2018 - Podcast from Day 3

This EULAR 2018 Podcast is a compilation of audio clips from EULAR in Amsterdam.

Click HERE to listen.

You can also listen on iTunes, Soundcloud or Stitcher. 

The RheumNow Week in Review – EULAR18 Abbreviated (6.15.18)

We're crazy busy at EULAR all week.  Instead of this review, we recommend that you tune into our multiple podcasts from experts and faculty attending EULAR 2018 in Amsterdam.  You can find these on iTunes, SoundCloud or Stitcher.

Tune in next week for the EULAR week in review!